NCT06756984

Brief Summary

Brief Summary The goal of this observational study is to evaluate the long-term outcomes of different surgical techniques for sacral Tarlov cysts in adult patients aged 18-75 years diagnosed with symptomatic sacral Tarlov cysts. The main questions it aims to answer are:

  • Does one surgical technique result in better pain relief (measured by VAS score) and functional recovery (measured by JOA score) compared to others?
  • How do different surgical techniques impact the long-term recurrence rate and complication rate? Researchers will compare three surgical techniques:
  • Partial cyst wall resection with nerve root sleeve plasty.
  • Partial cyst wall resection with nerve root sleeve reinforcement and reconstruction.
  • Autologous fat/muscle with fibrin glue microscopic cyst filling.
  • Undergo one of the three surgical procedures based on clinical indications.
  • Complete preoperative and postoperative assessments, including pain and functional scoring, as well as MRI evaluations at baseline and during follow-up.
  • Participate in a follow-up program for up to 2 years to monitor outcomes and recurrence.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started May 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
May 2025Dec 2026

First Submitted

Initial submission to the registry

December 24, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 3, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

May 13, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

1.1 years

First QC Date

December 24, 2024

Last Update Submit

May 12, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain Reduction Assessed by Visual Analog Scale (VAS)

    Baseline, 1 month, 3 months, 6 months, 12 months and 24 months postoperatively

  • Neurological Function Improvement Assessed by Japanese Orthopedic Association (JOA) Score

    Baseline, 1 month, 3 months, 6 months, 12 months and 24 months postoperatively

Secondary Outcomes (1)

  • Recurrence Rate of Sacral Tarlov Cysts

    12 months postoperatively and annually up to 2 years

Study Arms (3)

Partial Cyst Wall Resection with Nerve Root Sleeve Plasty

Participants in this group will undergo partial resection of the cyst wall combined with nerve root sleeve plasty. This technique involves reducing the cyst size and reconstructing the nerve root sleeve to restore nerve function and reduce symptoms.

Procedure: Partial Cyst Wall Resection with Nerve Root Sleeve Plasty

Partial Cyst Wall Resection with Nerve Root Sleeve Reinforcement and Reconstruction

Participants in this group will undergo partial resection of the cyst wall along with reinforcement and reconstruction of the nerve root sleeve. This method provides additional structural stability to the nerve root and aims to reduce the risk of recurrence and improve postoperative outcomes.

Procedure: Partial Cyst Wall Resection with Nerve Root Sleeve Reinforcement and Reconstruction:

Autologous Fat/Muscle with Fibrin Glue Microscopic Cyst Filling

Participants in this group will receive autologous fat or muscle tissue filling of the cyst cavity combined with fibrin glue sealing under microscopic guidance. This technique aims to obliterate the cyst cavity, prevent cerebrospinal fluid leakage, and enhance symptom relief and recovery.

Procedure: Autologous Fat/Muscle with Fibrin Glue Microscopic Cyst Filling

Interventions

Surgical technique involving partial removal of the cyst wall to decompress the nerve root, followed by plasty of the nerve root sleeve to restore nerve function and prevent recurrence.

Partial Cyst Wall Resection with Nerve Root Sleeve Plasty

Advanced surgical technique combining partial cyst wall removal with additional reinforcement and reconstruction of the nerve root sleeve to provide enhanced support and reduce the risk of cyst recurrence.

Partial Cyst Wall Resection with Nerve Root Sleeve Reinforcement and Reconstruction

Minimally invasive surgical technique where autologous fat or muscle tissue is used to fill the cyst cavity, and fibrin glue is applied to seal the defect, aiming to obliterate the cyst and prevent cerebrospinal fluid leakage.

Autologous Fat/Muscle with Fibrin Glue Microscopic Cyst Filling

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population includes adult patients aged 18-75 years diagnosed with symptomatic sacral Tarlov cysts, recruited from the Department of Neurosurgery at Beijing Jishuitan Hospital. Participants must exhibit persistent symptoms such as sacral or lower back pain, neurological deficits (e.g., numbness or weakness in the lower extremities), or bowel/bladder/sexual dysfunction attributable to the cyst, confirmed by MRI. The study focuses on individuals eligible for surgical intervention without significant comorbidities or prior related surgeries. This population represents a clinically relevant cohort for evaluating the efficacy and safety of different surgical techniques for sacral Tarlov cysts.

You may qualify if:

  • Age 18-75 years.
  • Diagnosed with symptomatic sacral Tarlov cysts confirmed by MRI.
  • Presence of at least one of the following symptoms:
  • Persistent sacral or lower back pain (VAS score ≥ 4).
  • Neurological deficits such as lower extremity numbness or weakness.
  • Bowel, bladder, or sexual dysfunction attributable to the cyst.
  • Eligible for surgical intervention based on clinical evaluation.
  • Willing and able to provide written informed consent.

You may not qualify if:

  • History of prior sacral Tarlov cyst surgery.
  • Concurrent spinal conditions requiring separate surgical intervention.
  • Active infection or systemic inflammatory disease.
  • Severe comorbidities that increase surgical risk (e.g., advanced cardiac or pulmonary disease).
  • Pregnancy or lactation.
  • Inability to comply with follow-up requirements.
  • Known allergy or contraindication to surgical materials (e.g., fibrin glue).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Tarlov Cysts

Interventions

Plastic Surgery Procedures

Condition Hierarchy (Ancestors)

CystsNeoplasmsPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc, Neurosurgeon, Department of Neurosurgery, Beijing Jishuitan Hospital

Study Record Dates

First Submitted

December 24, 2024

First Posted

January 3, 2025

Study Start

May 13, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 13, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share